In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Meatable hosts distinguished guests for EU’s first cultivated meat tasting
In the Netherlands, Meatable has hosted the European Union’s first cultivated meat tasting. Michelin-starred chef Ron Blaauw; Constantijn van Oranje, Prince of the Netherlands...
Cool as a cucumber (coating): Sweden’s Saveggy raises $2.1 million for edible produce preserver
In Sweden, foodtech startup Saveggy has raised €1.76 (US$2.1 million) to scale up an edible cucumber coating made from a proprietary formula of canola...
Designer develops chitin-based seed pods
In New York, designer Mara Zimmerman has developed SEAD, a seed delivery and cultivation material made from discarded seafood cells.
Specifically, Zimmerman uses chitin from...